Acadia Pharmaceuticals Inc
ACAD
Market Cap$2.82B
Close$
$18.95
10.9% upside
Current Fair Value
10.9% upsideUndervalued by 10.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.82 Billion |
|---|---|
| Enterprise Value | $2.38 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-0.37 |
| Beta | 1.06 |
| Outstanding Shares | 165,203,485 |
| Avg 30 Day Volume | 1,461,028 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -46.04 |
|---|---|
| PEG | 21.95 |
| Price to Sales | 4.27 |
| Price to Book Ratio | 8.54 |
| Enterprise Value to Revenue | 3.28 |
| Enterprise Value to EBIT | -32.47 |
| Enterprise Value to Net Income | -39 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
ESG Score
No data
About Acadia Pharmaceuticals Inc
CEO: Uli Hacksell